Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
adapt, AEs, affiliate, aminoglutarimide, AML, ASCA, avadomide, azacitidine, back, biggest, blood, BMS, Bristol, brochure, capture, cereblon, chiral, chronic, CMML, commandeer, compassionate, complementary, contemplate, contrary, COVID, CRBN, deadline, degradation, degraded, degrader, deploy, depth, deuterium, deuterx, DeutRx, Diffuse, disadvantage, diverge, enantiomer, engineered, evolution, explanatory, explicit, fallen, fatal, figure, Follicular, glue, Guillermo, hematopoietic, hope, Iberdomide, ID, immunomodulation, ineligibility, intermediate, intravenously, judgement, lab, Ladenburg, led, leukemia, lineage, lot, Lymphoma, macro, micro, MM, moiety, mouse, myelodysplastic, Myeloid, myeloma, myelomonocytic, NHL, notion, ourself, paragraph, Pomalyst, preapproval, promptly, proximity, qualitative, quantitative, recommence, reliant, Revlimid, robust, Rosenblum, SC, Seller, sequestration, Simultaneously, slower, Society, Squibb, stick, subcutaneously, subpopulation, suspected, switching, Tack, Thalmann, thirteen, weigh
Removed:
acquiring, amend, Bruce, Canada, clinic, compare, composed, Congressional, conversion, dated, detect, determinable, diligent, educational, exempt, existed, exploratory, expressly, extension, Falcon, format, fractional, hereof, HOTSHOT, Insider, internet, investing, Korea, lieu, Los, media, muscle, NOL, October, orally, parallel, passed, payroll, profit, recall, reconsider, recruitment, restated, retained, retrospectively, salary, Separation, simplify, South, speak, split, subsidiary, sum, surviving, training, Trump, unaudited, vested, voting
Filing tables
Filing exhibits
Related press release
Associated SLRX transcripts
SLRX similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
a.Registration Statement (Form S-8 No. 333-201816) pertaining to the 2014 Equity Incentive Plan, 2015 Equity Incentive Plan and 2015 Employee Stock Purchase Plan of Salarius Pharmaceuticals, Inc. (formerly known as Flex Pharma, Inc.);
b.Registration Statement (Form S-8 Nos. 333-210283, 333-216534, 333-223499, 333-230104, 333-246310 and 333-262896) pertaining to the 2015 Equity Incentive Plan and 2015 Employee Stock Purchase Plan of Salarius Pharmaceuticals, Inc. (formerly known as Flex Pharma, Inc.);
c.Registration Statement (Form S-3 No. 333-231010 and 333-252169) of Salarius Pharmaceuticals, Inc. (formerly known as Flex Pharma, Inc.); and
d.Registration Statement (Form S-1 No. 333-235879) of Salarius Pharmaceuticals, Inc.
of our report dated March 25, 2022, with respect to the consolidated financial statements of Salarius Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) of Salarius Pharmaceuticals, Inc. for the year ended December 31, 2021.
/s/ Ernst & Young LLP
Houston, Texas
March 25, 2022